# Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

> **NCT04972097** · NA · COMPLETED · sponsor: **Angiodynamics, Inc.** · enrollment: 121 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Irreversible Electroporation

## Key facts

- **NCT ID:** NCT04972097
- **Lead sponsor:** Angiodynamics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-29
- **Primary completion:** 2024-08-14
- **Final completion:** 2024-08-14
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04972097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04972097, "Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04972097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*